Literature DB >> 15531549

Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP.

Margreet Plaisier1, Kitty Kapiteijn, Pieter Koolwijk, Catherine Fijten, Roeland Hanemaaijer, Jos M Grimbergen, Adri Mulder-Stapel, Paul H A Quax, Frans M Helmerhorst, Victor W M van Hinsbergh.   

Abstract

In the endometrium, angiogenesis is a physiological process, whereas in most adult tissues neovascularization is initiated only during tissue repair or pathological conditions. Pericellular proteolysis plays an important role in angiogenesis being required for endothelial cell migration, invasion, and tube formation. We studied the expression of proteases by human endometrial microvascular endothelial cells (hEMVECs) and their involvement in the formation of capillary tubes and compared these requirements with those of foreskin MVECs (hFMVECs). Inhibition of urokinase and matrix metalloproteinase (MMP) both reduced tube formation in a fibrin or fibrin/collagen matrix. hEMVECs expressed various MMP mRNAs and proteins; in particular MMP-1, MMP-2, and membrane-type (MT)1-, MT3-, and MT4-MMPs. MT3- and MT4-MMP mRNA expressions were significantly higher in hEMVECs than in hFMVECs. Other MT-MMP mRNAs and MMP-9 were hardly detectable. Immunohistochemistry confirmed the presence of MT3-MMP in endothelial cells of endometrial tissue. Overexpression of tissue inhibitor of MMP (TIMP)-1 or TIMP-3 by adenoviral transduction of hEMVECs reduced tube formation to the same extent, whereas only TIMP-3 was able to inhibit tube formation by hFMVECs. Tube formation by hEMVECs was partly inhibited by the presence of anti-MT3-MMP IgG. Thus, in contrast to tube formation by hFMVECs, which largely depends on MT1-MMP, capillary-like tube formation by hEMVECs is, at least in part, regulated by MT3-MMP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531549     DOI: 10.1210/jc.2004-0860

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

2.  Regulation of matrix metalloproteinase expression by dynamic tensile strain in rat fibrochondrocytes.

Authors:  J Deschner; B Rath-Deschner; S Agarwal
Journal:  Osteoarthritis Cartilage       Date:  2005-11-14       Impact factor: 6.576

3.  Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).

Authors:  Joji Iida; Krista L Wilhelmson; Janet Ng; Peter Lee; Charlotte Morrison; Eric Tam; Christopher M Overall; James B McCarthy
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

4.  A cell-based model of extracellular-matrix-guided endothelial cell migration during angiogenesis.

Authors:  Josephine T Daub; Roeland M H Merks
Journal:  Bull Math Biol       Date:  2013-03-15       Impact factor: 1.758

Review 5.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

6.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

7.  Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesis.

Authors:  Joanne Shi; Mi-Young Son; Susan Yamada; Ludmila Szabova; Stacie Kahan; Kaliopi Chrysovergis; Lauren Wolf; Andrew Surmak; Kenn Holmbeck
Journal:  Dev Biol       Date:  2007-10-23       Impact factor: 3.582

8.  MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer.

Authors:  Lujun Chen; Qi Zhou; Bin Xu; Jian Liu; Liangrong Shi; Danxia Zhu; Changping Wu; Jingting Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 9.  Breast cancer progression: insights into multifaceted matrix metalloproteinases.

Authors:  Vincent Chabottaux; Agnès Noel
Journal:  Clin Exp Metastasis       Date:  2007-10-30       Impact factor: 5.150

Review 10.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.